Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Injections × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Breast Neoplasms 17 Advanced Solid Tumors 16 Myelodysplastic Syndromes 14 Advanced Solid Tumor 11 Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelomonocytic, Chronic 8 Neoplasms 7 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Triple Negative Breast Neoplasms 5 Solid Tumor 5 Ovarian Neoplasms 5 Advanced Solid Tumour 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Lymphoma, B-Cell 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Advanced Malignant Solid Tumor 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡